Insiders Keymed Biosciences Inc.

Equities

Delayed Hong Kong S.E. Other stock markets 11:38:30 2024-05-07 pm EDT			5-day change	1st Jan Change
36.6 ^HKD	+2.81%		+0.83%	-25.66%

Apr. 30	Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA	MT
Apr. 29	Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points	MT

Keymed Biosciences Inc. Announces Board and Committee Changes	23-04-17	CI
Keymed Biosciences Inc. Announces Executive Changes	22-03-29	CI
Keymed Biosciences Inc. Announces Resignation of Dong Lyu as Non-Executive Director	22-03-29	CI

No results for this search